You are here

  • Home
  • Archive
  • Volume 24, Issue 1
  • Bridging anticoagulation therapy with low molecular weight heparin in patients with atrial fibrillation following a stroke is associated with adverse events

Article metrics

Article menu
Download PDFPDF
Commentary
Adult nursing
Bridging anticoagulation therapy with low molecular weight heparin in patients with atrial fibrillation following a stroke is associated with adverse events

 

Online download statistics by month:

Online download statistics by month: November 2019 to March 2024

AbstractFullPdf
Nov 201922477
Dec 20194392118
Jan 2020575114
Feb 20202873117
Mar 20202628132
Apr 202040635
May 20206832
Jun 202015684
Jul 20208120
Aug 20205641
Sep 20207730
Oct 202010542
Nov 202011972
Dec 2020212119
Jan 20213083114
Feb 20213321820
Mar 2021202149
Apr 202115161
May 20218794
Jun 2021755
Jul 202115104
Aug 20211542
Sep 2021743
Oct 20217553
Nov 202111462
Dec 20214644
Jan 20225953
Feb 20226740
Mar 20229750
Apr 20227920
May 202211762
Jun 20226730
Jul 202210130
Aug 2022152123
Sep 20228771
Oct 202215673
Nov 202216570
Dec 202216750
Jan 202316580
Feb 202319370
Mar 202315240
Apr 20237570
May 202310980
Jun 2023107110
Jul 202311251
Aug 20238040
Sep 20239150
Oct 202313580
Nov 202313630
Dec 202313450
Jan 20242920
Feb 202410371
Mar 202496101
Total12409384149